Nadav Kidron
2017
In 2017, Nadav Kidron earned a total compensation of $1.2M as President and Chief Executive Officer and director at Oramed Pharmaceuticals, a 137% increase compared to previous year.
Compensation breakdown
| Bonus | $123,000 |
|---|---|
| Option Awards | $585,150 |
| Salary | $399,804 |
| Other | $45,579 |
| Total | $1,153,533 |
Kidron received $585.2K in option awards, accounting for 51% of the total pay in 2017.
Kidron also received $123K in bonus, $399.8K in salary and $45.6K in other compensation.
Rankings
In 2017, Nadav Kidron's compensation ranked 8,283rd out of 14,666 executives tracked by ExecPay. In other words, Kidron earned more than 43.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,283 out of 14,666 | 44th |
Division Manufacturing | 3,134 out of 5,768 | 46th |
Major group Chemicals And Allied Products | 1,032 out of 2,074 | 50th |
Industry group Drugs | 812 out of 1,730 | 53rd |
Industry Pharmaceutical Preparations | 635 out of 1,329 | 52nd |
Source: SEC filing on July 30, 2018.
Kidron's colleagues
We found two more compensation records of executives who worked with Nadav Kidron at Oramed Pharmaceuticals in 2017.